Market Value276,541,000
Total Holdings49
File Date2019-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
FENC / Fennec Pharmaceuticals Inc.
NXTC / NextCure, Inc.
FGEN / FibroGen, Inc.
AQST / Aquestive Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
AWH / Aspira Women's Health Inc.
RDUS / Radius Recycling, Inc.
THOR / Synthorx Inc
TPTX / Turning Point Therapeutics Inc
QTRX / Quanterix Corporation
SBBP / Strongbridge Biopharma plc
PTCT / PTC Therapeutics, Inc.
FBIO / Fortress Biotech, Inc.
BOLD / Boundless Bio, Inc.
ZYME / Zymeworks Inc.
SWAV / Shockwave Medical, Inc.
AXGN / Axogen, Inc.
EPZM / Epizyme Inc
QURE / uniQure N.V.
CBAY / CymaBay Therapeutics, Inc.
FLXN / Horizon Funds - Horizon Flexible Income ETF
VKTX / Viking Therapeutics, Inc.
AVTX / Avalo Therapeutics, Inc.
FTSV / Forty Seven, Inc.
ODT / Odonate Therapeutics Inc
RARX / Ra Pharmaceuticals, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
MGTA / Magenta Therapeutics Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
US28249H1041 / Eidos Therapeutics, Inc.
ARQL / ArQule, Inc.
0HBB / Aimmune Therapeutics Inc
ATXI / Avenue Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
CDXS / Codexis, Inc.
ARVN / Arvinas, Inc.
CCXI / ChemoCentryx Inc
FWBI / First Wave BioPharma, Inc.
ITCI / Intra-Cellular Therapies, Inc.
ASMB / Assembly Biosciences, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
BHVN / Biohaven Ltd.
APTO / Aptose Biosciences Inc.
STXS / Stereotaxis, Inc.
NLTX / Neoleukin Therapeutics, Inc.
CMRX / Chimerix, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
CARA / Cara Therapeutics, Inc.
PLX / Protalix BioTherapeutics, Inc.
BPMC / Blueprint Medicines Corporation
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
LXRX / Lexicon Pharmaceuticals, Inc.
XOMA / XOMA Royalty Corporation
CRNX / Crinetics Pharmaceuticals, Inc.
ETON / Eton Pharmaceuticals, Inc.
OCUL / Ocular Therapeutix, Inc.
TGTX / TG Therapeutics, Inc.
HROW / Harrow, Inc.
CYTK / Cytokinetics, Incorporated